CardioNexus gets FDA ok for cardiac ultrasound system

CardioNexus, a joint venture between Panasonic and Houston-based Fairway Medical Technologies, has received the FDA's nod for an ultrasound system for the early detection of heart disease.

The company's CardioHealth Station uses a portable ultrasound system for non-invasive heart examinations. It can detect arterial plaque and measure the thickness of arterial walls, the Houston Business Journal notes.

Last October, Panasonic announced it had completed an investment in CardioNexus as part of a move to establish itself as a global leader in personalized preventive medicine. And the following month, Panasonic said it hoped to start CardioHealth system sales as soon as it received FDA approval.

- see the Houston Business Journal story

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.